| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-01-31 | FY 2023
FILED 2024-01-31 |
|---|---|---|---|
| Revenue (Total Sales) | $7.21B | $6.13B | $5.50B |
| YoY Revenue Growth % | +17.5% | +11.5% | — |
| Gross Profit | $6.56B | $5.55B | — |
| Gross Margin % | 91.0% | 90.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.58B | $1.35B | $1.13B |
| Operating Margin % | 21.9% | 22.1% | 20.5% |
| Net Income (GAAP) | $1.12B | $1.11B | $906.0M |
| EBITDA (Normalized) | $1.61B | $1.39B | $1.33B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $2.45B | $1.61B | $1.31B |
| Capital Expenditures (CapEx) | $43.0M | $40.0M | $247.4M |
| Free Cash Flow (FCF) | $2.41B | $1.57B | $1.07B |
| FCF Margin % | 33.4% | 25.6% | 19.4% |
| Return on Invested Capital (ROIC %) | 33.6% | 30.1% | 5.3% |
| Cash & Short-Term Equivalents | $2.25B | $1.60B | — |
| Total Debt (Short + Long Term) | $2.92B | $2.53B | $6.50B |
| Total Stockholders' Equity | $3.04B | $2.62B | $13.34B |